| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5674497 | Revue de Pneumologie Clinique | 2016 | 4 Pages |
Abstract
This observation presents the diagnostic and therapeutic difficulties of the lung parenchymental disease in intensive care. OP must be recognized. ECCO2R can be used in severe OP as a bridge to recovery while waiting for the corticosteroid efficacy.
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
G. Rival, O. Millet, G. Capellier,